Skip to main content
. 2023 Nov 24;11:1269805. doi: 10.3389/fpubh.2023.1269805

Table 1.

Characteristics of the population.

Age groups All (n = 668) 0–1 Y (n = 56) 2–5Y (n = 67) 6–17Y (n = 75) 18–29Y (n = 106) 30–44Y (n = 122) 45–64Y (n = 146) 65–75Y (n = 60) 75–94Y (n = 36)
Female 409(59) 28(50) 34(50.7) 42(56) 67(63.2) 85(69.7) 89(69.9) 36(60) 24(63.1)
Symptoms n (%)
Rhinitis 565(84.3) 49(87.5) 63(94.0) 67(89.3) 92(86.8) 101(82.8) 113(79.4) 48(80) 32(84.2)
Fever 279(41.6) 22(39.3) 42(62.7) 38(50.7) 44(41.5) 46(37.7) 61(41.7) 15(25) 11(28.9)
Cough 533(79.6) 45(80.4) 49(73.1) 61(81.3) 83(78.3) 95(77.9) 116(79.4) 60(90) 30(78.9)
Dyspnea 63(9.4) 14(25) 12(17.9) 3(4) 8(7.5) 9(7.4) 22(15.1) 8(13.3) 5(13;2)
Headache (n = 548) 208(37.8) NE NE 23(30.7) 46(43.3) 52(42.6) 60(41.1) 21(35) 4(10.5)
Diagnosis n (%)
Upper ARIs 433(64.6) 39 (69.6) 49 (73.1) 45 (60.0) 78 (63.6) 86 (70.5) 83 (56.9) 29 (48.3) 24(63.2)
Lower ARIs 143(21.3) 16(28.6) 17 (25.4) 10 (13.3) 11 (10.4) 14 (13.5) 38 (26.0) 24 (40.0) 13(34.2)
Flu-like syndrome 94(14.1) 1 (1.8) 1 (1.5) 20 (26.7) 17 (16.0) 22 (18.0) 25 (17.1) 7 (11.7) 1 (2.6)
Viruses n (%)
Negative 227(33.9) 6(10.7) 7(10.4) 18(24) 34(32.1) 53(43.4) 64(43.9) 27(45) 18(47.4)
HRV 203(30.3) 30(53.6) 36(53.7) 23(30.7) 32(30.2) 32(26.2) 35(23.0) 10(16.7) 5(13.1)
Influenza viruses 95(14.2) 2(3.6) 14(20.9) 19(25.3) 16(15.1) 15(12.3) 16(10.9) 9(15) 4(10.5)
CoV 60(9.0) 5(8.9) 3(4.5) 7(9.3) 12(11.3) 13(10.7) 13(8.9) 2(3.3) 5(13.1)
PIV 42(6.3) 6(10.7) 5(7.4) 6(8.0) 8(7.5) 4(3.2) 8(5.4) 5(8.3) 0
RSV 39(5.8) 9(16.1) 2(3.0) 2(2.7) 6(5.7) 2(1.6) 11(7.5) 2(3.3) 5(13.1)
HMPV 34(5.1) 5(8.9) 4(6.0) 7(9.3) 2(1.9) 7(5.8) 3(2.0) 5(8.3) 1(2.6)
ADV 18(2.7) 6(10.7) 10(14;9) 1(1.3) 0 0 1(0.7) 0 0
BoV 12(1.8) 6(10.7) 4(6.0) 0 0 1(0.8) 1(0.68) 0 0
Codetection 53(7.9) 16(28.6) 15(22.4) 8(10.7) 4(3.8) 4(3.3) 6(4.1) 0 0

Upper ARIs included rhinitis, sinusitis, pharyngitis, angina, laryngitis, and otitis. Lower ARIs included asthma, bronchitis, and community-acquired pneumonia. NE, not evaluable. Multiplex PCR test results: among the 668 samples tested (97.5% patients), 443 (66%) were positive for at least one virus (Table 2). The median [IQ25-75] age and SD of patients with negative or positive samples were, respectively, 45 [1–92] years and 27 [0.3–94] years (p < 0.0001), and 3 [2-5] days and 2 [2-8] days. The multivariate analysis confirmed that negative samples were independently associated with age by year (p < 0.00001) and with the SD by day (p < 0.00001) according to the onset of symptoms.